Evox Therapeutics
PrivateLast Round
Series C
Feb 18, 2021
Total Funding Raised
$168.25M
Company Overview
Evox Therapeutics is a biotechnology company that develops exosome-based therapeutics for the treatment of severe rare, neurological, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evox Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Evox Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 18, 2021 | ||||
| Convertible Debt | Jun 9, 2020 | ||||
| Grant | Mar 22, 2019 | ||||
| Grant | Nov 13, 2018 | ||||
| Grant | Oct 1, 2018 | ||||
Series B | Sep 3, 2018 |
Evox Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series C |
| Innovate UK | Grant |
| UK government | Grant |
| GV | Series B, Series C |
| Cowen Private Investments | Series B, Series C |
| Duchenne UK | Grant |
| Oxford Science Enterprises | Series B, Series C, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2018
$45M round led by Redmile Group
Evox Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evox Therapeutics's valuation, stock price, and market status.